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more [1]. An estimated 1.5 million deaths – the equivalent of 8
jumbo jets crashing every day – could be averted if global vaccina-
tion uptake improved [2]. Yet, increasing vaccine coverage is not as
simple as educating people about the benefits of vaccination. There
are many barriers and drivers which affect vaccine uptake, ranging
from logistics such as ensuring people have access to and are aware
of affordable vaccines, to socio-psychological factors underpinning
people’s acceptance to be vaccinated [3]. Until recently, much that
had been done to address vaccine hesitancy and low vaccine cov-
erage was based on untested beliefs or good ideas rather than on
solid evidence, but this is changing. This special issue, stemming
from an annual meeting on vaccine confidence and coverage [4],
builds on an increasing body of empirical evidence seeking to iden-
tify the determinants of vaccine acceptance and uptake. Impor-
tantly, it also echoes changes in this field, by moving beyond
understanding to action, highlighting a number of social and
behavior change interventions that have been designed and tested
for impact. In the remainder of this Editorial, we highlight the key
points from the contributing articles and their implications for
designing effective communication and intervention strategies to
increase vaccine acceptance and uptake.
1. Communicating your reasons are not enough: Begin by
understanding your target audience
‘‘People just need to understand the benefits and value of vacci-
nes!” This commonly-heard cry unfortunately assumes that low
acceptance is due to lack of knowledge and thus providing facts
and arguments will suffice to induce action. Most smokers under-
stand the benefits and value of quitting smoking, illustrating that
knowledge attainment does not necessarily influence health
related behaviors. The research included in this issue highlights
that vaccine hesitancy has numerous possible demographic and
socio-psychological root causes, many of which are not knowl-
edge-related. The development of effective strategies to sustain
trust in vaccination programs requires an understanding of the
particular social and psychological factors that determine the vac-
cination decisions of different populations with different vaccines.
In this issue, a number of studies which variously investigated
hesitant compliers (concerned but fully-vaccinated parents), hesi-
tant mothers, pregnant women, parents of young children, and
community leaders and members identified both common (eg.
trust) and specific factors that may underpin vaccine acceptance
in these different groups [5–10]. The important role in vaccineacceptance and uptake of communities, which may manifest
through co-localization or common interests, is also highlighted
[11].
2. Saying it is not enough: Target your communications to the
needs of your audience
Communication is important to sustaining uptake in any vacci-
nation program, and while the content should be evidence-based,
the development and implementation of communication is not
always grounded in communication science principles. As a result,
when vaccination communication strategies are tested for efficacy
in terms of intentions to vaccinate they may often be ineffective, or
may even backfire [12]. Through understanding the different com-
munication needs of parents with different attitudes to vaccina-
tion, the study by Berry et al. helps facilitate tailoring of a
communications intervention [8]. The lessons learned from an
online hub of pro-vaccine information, that highlight the impor-
tance of transparency and credibility to build trust, and of tone,
style (storytelling), and content (videos and animations) to
increase resonance with readers provides a practical playbook for
other online, and interpersonal, communications projects [13].
Ohlrogge et al. found that national influenza communications in
Europe were often inconsistent with national recommendations
and were rarely evaluated [14]. One challenge to the development
of effective communications is a lack of consistent and validated
outcome measures. This has, in part, been addressed by Kaufman
et al., whose mapping of core outcome domains for communication
on childhood vaccination allows the selection of appropriate mea-
sures for different communications approaches [15]. Parrish-
Sprowl argues that research and practice that only account for
message content misses the impact of the broader communication
process and context [16]. Or, the way a healthcare professional
(HCP), for example, talks about vaccination to a patient is as impor-
tant, or perhaps more so, that what they actually say in terms of
behavioral outcomes.
3. Communicating to people is not enough: Listen to and
engage healthcare professionals too
A recommendation from an HCP consistently emerges as an
important determinant of vaccination acceptance. While HCPs
are usually the most trusted source of information on vaccines,
they themselves may be unsure about vaccination or vaccination
conversations with their patients. Attwell et al. observed that while
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beliefs and concerns related to vaccination [17]. Two new validated
scales for measuring motivation of HCPs towards influenza vacci-
nation and towards advocating influenza vaccination [18] can be
used to better understand the drivers of hesitancy among HCPs.
A six-country study showed that these scales can identify
meaningful and actionable clusters of HCPs, which may inform
the tailoring of communications or interventions according to
underlying motivations [19]. Equipping HCPs with tools to com-
municate with their patients may also contribute to establish a
more trusting and constructive dialogue. For example, an interven-
tion based on motivational interviewing, which acknowledges the
importance of the communication process and context through
emphasizing the importance of respect and empathy, and of under-
standing the position of the parent regarding vaccines, showed
effectiveness on acceptance, intention to vaccinate, and actual vac-
cine coverage [20].
4. Communicating is not enough: Design culturally targeted
interventions to improve access to vaccines
Bedford et al underscore the importance of viewing vaccine
hesitancy as only one possible determinant of under-vaccination
[21]. In India, where just over half of infants are fully vaccinated,
mothers reported that non-vaccination of their children was vari-
ously due to challenges related to awareness, acceptance and
affordability (both financial and non-financial costs) [22]. While
Nagar et al.’s randomized controlled trial of a multicomponent
intervention with a culturally tailored digital vaccination record
and reminders in rural India did not significantly increase timely
vaccination, the inclusion of process outcomes will allow further
adaptation of the approach to better match communication to
the user [23].
The contributions from this special issue illustrate implications
for designing effective communication and intervention strategies
to increase vaccine acceptance and uptake. Clearly, context matters
and communications must be designed to fit the needs and moti-
vations of individuals. However, such communication needs to be
designed based on evidence and with validated process and out-
come measures. This requires that national authorities, research-
ers, HCPs and public health professionals understand and act
upon the fact that that there is no one-size fits all strategy to solve
vaccine hesitancy and that collaborative efforts are needed and
must be sustained over time. To sustain and extend the remarkable
successes of global immunization programs, governments and
funding agencies should not just expand funding and support for
research, monitoring and evaluation related to vaccine acceptance
and uptake, but they should also mandate that efforts are evidence
based and that communications and interventions are culturally
and context appropriate.
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